Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Investor Alert: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), filed a lawsuit in the U.S. District Court for the District of Connecticut over alleged violations of Federal Securities Laws by Achillion Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between April 21, 2012 and September 27, 2013, including the safety and suitability of its premier investigative drug for the treatment of hepatitis, sovaprevir.
View full press release